In the era of cancer immunotherapy, exploring co-regulation patterns of PD-L1 expression and their oncological therapeutic potential provides new perspectives for clinical diagnosis, individualized comprehensive treatment, and translational research of BCa. The gene discussed is CD274; the disease is cancer.